跳至主要内容
临床试验/EUCTR2013-002386-18-DE
EUCTR2013-002386-18-DE进行中(未招募)1 期

etwork connectivity and inhibitory control under atomoxetin challenge - A pharamacological resting state and inhibitory task fMRI studyin patients with ADHD - CAIAC

RWTH Aachen Clinical Trials Center Aachen (CTC-A)0 个研究点目标入组 52 人开始时间: 2015年11月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Age 18-45 years
  • Diagnosis of ADHD (patients) or no axis I disorder (controls) according the DSM IV
  • No substance abuse/ dependency
  • Understanding of the study information and declaration of agreement
  • Ability to read, understand and speak German
  • No severe medical disorders
  • No risk for suicide
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 52
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Drug dependence or the a positive drug screening
  • Other Severe physical disorders
  • Current pharmacological therapy because of another psychiatric disorder
  • Risk for seizure or cardiac problems
  • Impaired liver and renal function
  • Significant deviations in regard to clinical chemistry, haematology or EKG
  • Relationship of dependency with the sponsor or the investigator
  • Unable to keep to the study protocol
  • Known Intolerance of the study medication
  • fMRI scanner incompatibility

研究者

发起方
RWTH Aachen Clinical Trials Center Aachen (CTC-A)

相似试验